Strategic research agenda: National research programme
in viruses and pandemics

The goal of the research program on viruses and pandemics is to contribute to new knowledge about viral diseases. More knowledge is needed both about how they spread and how future pandemics can be prevented.

This strategic research agenda guides the work ahead and outlines five focus areas for research within the program:

  • viruses, virus-induced disease states, and fundamental disease mechanisms
  • mechanisms for the emergence and spread of zoonoses with pandemic potential, as well as strategies for prevention and management of transmission
  • development of antiviral medicines, vaccines, and diagnostics
  • societal measures arising from pandemics and their effects on people's living conditions and health
  • organization, governance, and coordination (infrastructures) of critical societal functions during a pandemic.

The research agenda has been developed by the Swedish Research Council with the support of a program committee and focus groups with experts from relevant research areas. The experts have identified knowledge gaps within each focus area.

Read more about the national research program on viruses and pandemics

MORE WITHIN THE SAME SUBJECT AREA

  1. Inauguration of the new centre of excellence Chemical Mechanisms of Life

    On 12 of April, there will be an inauguration of one of the new centres of excellence with funding from the Swedish Research Council: Chemical Mechanisms of Life – an interdisciplinary centre for research into the chemistry of life. Mattias Marklund,...

  2. The Swedish Research Council’s centres of excellence

    The Swedish Research Council is funding 15 centres of excellence as from 2024. The centres, which are being built up, shall carry out ground-breaking research and educational activities around a central theme.

  3. Just over 75 per cent of clinical studies registered after one year

    As from 2022, all clinical studies funded by the Swedish Research Council shall be registered in a public database. A recent follow-up shows that the majority of the clinical studies awarded funding in 2022 have been registered.